ArticleBlood cancer journal2026
Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients.
Niels W C J van de Donk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.